Reuters reports on the FDA's ongoing review of popular peptides amid continued consumer demand and increasing industry attention. As regulatory conversations progress, organizations committed to education, scientific integrity, and best practices will continue to play an important role in supporting the responsible evolution of the peptide industry.
Read the Full Article